Sweden’s Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization ...

Swiss generics and biosimilars major Sandoz has announced a strategic agreement with Germany’s Evotec to acquire all issued ...

Danish pharma major Novo Nordisk today announced financial results for the first nine months of 2025, showing that group net ...

Trade group Pharmaceutical Research and Manufacturers of America (PhRMA) recently submitted comments to inform the Office of ...

US biopharma firm Viridian Therapeutics today announced the successful submission of its biologics license application (BLA) to the US Food and Drug Administration (FDA) for veligrotug, the company’s ...

In a further step in South Korea-based Celltrion’s ambitions to diversify from its core biosimilars focus, the company has ...

US pharma major Eli Lilly has revealed plans to build a new $3 billion manufacturing facility in Katwijk, the Netherlands, ...

US pharma giant Pfizer (NYSE: PFE) reported financial results for the third quarter of 2025 on Tuesday. Revenues for the ...

The bidding war for US obesity focused biotech Metsera, which has attracted offers from Pfizer and Novo Nordisk , and ...

The US Food and Drug Administration (FDA) has approved Belgium drugmaker UCB’s Kygevvi (doxecitine and doxribtimine) powder ...

US biopharma Vertex Pharmaceuticals has reported consolidated financial results for the third quarter of 2025 and refined its ...

US pharma giant Merck & Co, known as MSD outside of the USA and Canada, today announced that the company, through subsidiary ...